Novartis Ireland HCP Portal
Published on Novartis Ireland HCP Portal (https://prod.hcp.novartis.ie)

Home > Printer-friendly > Leqvio® resources

Leqvio® resources [1]

Prescribing information [2]

________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Inclisiran is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:

  • in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin, or
  • alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.1

 

Leqvio® is not reimbursed in Ireland at this time.

 

Explore our growing repository of resources designed to provide useful information on Leqvio® and other relevant topics for healthcare professionals treating patients with ASCVD.

 

Rate this content: 
Average: 1.6 (23 votes)

Source URL:https://prod.hcp.novartis.ie/medicines/cardiology/leqvio/leqvio-resources

Links
[1] https://prod.hcp.novartis.ie/medicines/cardiology/leqvio/leqvio-resources [2] https://prod.hcp.novartis.ie/sites/health.novartis.co.uk/files/inclisiran-pi.pdf